Determination of Regulatory Review Period for Purposes of Patent Extension; ALFAPUMP

Summary

The FDA has determined the regulatory review period for ALFAPUMP, a medical device, and is publishing this notice as required by law. The review period is due to a patent extension application submitted to the USPTO.